OneDigital Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,333
Closed -$241K 823
2022
Q3
$241K Buy
+7,333
New +$269K 0.01% 656
2022
Q2
Sell
-6,059
Closed -$278K 717
2022
Q1
$278K Buy
6,059
+1,838
+44% +$87.6K 0.01% 620
2021
Q4
$258K Buy
4,221
+1,335
+46% +$92.3K 0.01% 644
2021
Q3
$216K Buy
+2,886
New +$242K 0.01% 663

Other funds holding ARKG

OneDigital Investment Advisors's ARKG Position: Q4 2022 in Review

OneDigital Investment Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 7,333 shares — an estimated $241K sold.

OneDigital Investment Advisors first reported a position in ARKG in Q3 2021 and held it in 4 quarters. The position peaked at $278K in Q1 2022. 320 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

  • OneDigital Investment Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
  • OneDigital Investment Advisors sold 7,333 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $241K.
  • OneDigital Investment Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 4 quarters.
  • OneDigital Investment Advisors's ARK Genomic Revolution ETF position peaked at $278K in Q1 2022.
  • 320 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on OneDigital Investment Advisors's 13F filing for Q4 2022, filed 2 Feb 2023.